Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,353,932
+$142,415 QoQ
Shares Held
20,308
-0.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#659
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. AMGN ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
This page
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,353,932 | 20,308 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,211,517 | 20,496 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,789,064 | 20,742 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,994,774 | 21,243 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,462,872 | 23,147 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,479,616 | 20,798 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,065,538 | 19,435 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $6,152,599 | 19,095 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,638,777 | 24,448 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,542,487 | 23,011 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,076,064 | 17,624 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,697,980 | 21,201 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,508,116 | 20,305 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $5,099,958 | 21,096 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,561,664 | 21,176 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,831,899 | 21,437 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,068,145 | 24,941 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,104,745 | 25,245 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $4,493,325 | 19,973 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,540,502 | 21,352 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,635,150 | 19,016 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $13,296,157 | 53,439 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,963,590 | 17,239 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,685,439 | 18,435 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,758,239 | 20,174 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,908,971 | 29,147 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||